This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin—which is found in magic mushrooms—are being explored for all sorts of health applications, including treatments for depression, PTSD, addiction, and even obesity. Over…
Graham & Walker’s Leslie Feinzaig and XYZ Venture’s Ross Fubini share the secrets for founders — and VCs — to make the most of the current fast pace of dealmaking.
Many business leaders believe they’ve got a “speed problem,” but the real issue is an execution leak that shows up well before the slowdown even becomes obvious.